|
|
40
|
|
|
B0731
|
|
|
KEPPRA 100MG/ML SYRUP (GSK/COL) LEVETIRACETAM
|
|
|
LEVETIRACETAM
|
|
|
KEPPRA
|
|
|
300ML
|
|
|
B
|
|
|
91.72
|
|
|
0.31
|
|
|
100MG/ML
|
|
|
SYRUP
|
|
|
0
|
|
|
ML
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
Anti-Epileptic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
281292
|
|
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|